Skip to main content
. 2011 Feb 3;4:43–53. doi: 10.2147/IDR.S12714

Table 4.

Summary of voriconazole-mediated drug–drug interactions

Type of interaction, drug Recommendation
Decreases voriconazole levels
Carbamazepine Contraindicated
Long-acting barbiturates Contraindicated
Rifampin Contraindicated
Ritonavir Avoid unless benefit outweighs risk
Levels increased by voriconazole
Astemizole Contraindicated
Cisapride Contraindicated
Cyclosporine Reduce cyclosporine dosage by half and monitor cyclosporine levels
Ergot alkaloids Contraindicated
Omeprazole Reduce dosage by half
Quinidine Contraindicated
Sirolimus Contraindicated
Reduce sirolimus dose by 90% and monitor sirolimus levels
Tacrolimus Reduce tacrolimus dosage by two-thirds and monitor tacrolimus levels
Terfenadine Contraindicated
Warfarin Monitor prothrombin time and international normalized ratio
Decreases voriconazole levels and increases other drug levels
Rifabutin Contraindicated
Phenytoin Double voriconazole dosage and monitor for increased phenytoin levels
Efavirenz Double voriconazole dosage and reduce efavirenz dose by half
Levels likely increased by voriconazole: sulfonylureas, statins, vinca alkaloids, calcium channel blockers, benzodiazepines Monitor effect of drug and consider decreasing dosage when voriconazole is started

Modified from reference 27.